Literature DB >> 20696926

Missense mutations in dystrophin that trigger muscular dystrophy decrease protein stability and lead to cross-beta aggregates.

Surinder M Singh1, Narsimulu Kongari, Javier Cabello-Villegas, Krishna M G Mallela.   

Abstract

A deficiency of functional dystrophin protein in muscle cells causes muscular dystrophy (MD). More than 50% of missense mutations that trigger the disease occur in the N-terminal actin binding domain (N-ABD or ABD1). We examined the effect of four disease-causing mutations--L54R, A168D, A171P, and Y231N--on the structural and biophysical properties of isolated N-ABD. Our results indicate that N-ABD is a monomeric, well-folded alpha-helical protein in solution, as is evident from its alpha-helical circular dichroism spectrum, blue shift of the native state tryptophan fluorescence, well-dispersed amide crosspeaks in 2D NMR (15)N-(1)H HSQC fingerprint region, and rotational correlation time calculated from NMR longitudinal (T(1)) and transverse (T(2)) relaxation experiments. Compared to WT, three mutants--L54R, A168D, and A171P--show a decreased alpha-helicity and do not show a cooperative sigmoidal melt with temperature, indicating that these mutations exist in a wide range of conformations or in a "molten globule" state. In contrast, Y231N has an alpha-helical content similar to WT and shows a cooperative sigmoidal temperature melt but with a decreased stability. All four mutants experience serious misfolding and aggregation. FT-IR, circular dichroism, increase in thioflavin T fluorescence, and the congo red spectral shift and birefringence show that these aggregates contain intermolecular cross-beta structure similar to that found in amyloid diseases. These results indicate that disease-causing mutants affect N-ABD structure by decreasing its thermodynamic stability and increasing its misfolding, thereby decreasing the net functional dystrophin concentration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696926      PMCID: PMC2930578          DOI: 10.1073/pnas.1008818107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Role of arginine in the stabilization of proteins against aggregation.

Authors:  Brian M Baynes; Daniel I C Wang; Bernhardt L Trout
Journal:  Biochemistry       Date:  2005-03-29       Impact factor: 3.162

2.  Side chain and backbone contributions of Phe508 to CFTR folding.

Authors:  Patrick H Thibodeau; Chad A Brautigam; Mischa Machius; Philip J Thomas
Journal:  Nat Struct Mol Biol       Date:  2004-12-26       Impact factor: 15.369

Review 3.  Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy.

Authors:  Clare L Batchelor; Steve J Winder
Journal:  Trends Cell Biol       Date:  2006-03-03       Impact factor: 20.808

Review 4.  Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.

Authors:  Michael J Blankinship; Paul Gregorevic; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2005-12-19       Impact factor: 11.454

Review 5.  Dystrophin, its interactions with other proteins, and implications for muscular dystrophy.

Authors:  James M Ervasti
Journal:  Biochim Biophys Acta       Date:  2006-06-07

6.  A signaling role for dystrophin: inhibiting skeletal muscle atrophy pathways.

Authors:  David J Glass
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

7.  The crystal structure of the actin binding domain from alpha-actinin in its closed conformation: structural insight into phospholipid regulation of alpha-actinin.

Authors:  Giacomo Franzot; Björn Sjöblom; Mathias Gautel; Kristina Djinović Carugo
Journal:  J Mol Biol       Date:  2005-04-22       Impact factor: 5.469

8.  Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association.

Authors:  I N Rybakova; J M Ervasti
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

9.  Intermolecular beta-sheet results from trifluoroethanol-induced nonnative alpha-helical structure in beta-sheet predominant proteins: infrared and circular dichroism spectroscopic study.

Authors:  A Dong; J Matsuura; M C Manning; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  1998-07-15       Impact factor: 4.013

10.  Correlation of levels of folded recombinant p53 in escherichia coli with thermodynamic stability in vitro.

Authors:  Sebastian Mayer; Stefan Rüdiger; Hwee Ching Ang; Andreas C Joerger; Alan R Fersht
Journal:  J Mol Biol       Date:  2007-06-22       Impact factor: 5.469

View more
  33 in total

1.  Novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy.

Authors:  Gyula Acsadi; Steven A Moore; Angélique Chéron; Olivier Delalande; Lindsey Bennett; William Kupsky; Mohammad El-Baba; Elisabeth Le Rumeur; Jean-François Hubert
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Dystrophin's tandem calponin-homology domains: is the case closed?

Authors:  Neville R Kallenbach; Roberto Dominguez
Journal:  Biophys J       Date:  2012-11-07       Impact factor: 4.033

3.  The Structurally Plastic CH2 Domain Is Linked to Distinct Functions of Fimbrins/Plastins.

Authors:  Ruihui Zhang; Ming Chang; Meng Zhang; Youjun Wu; Xiaolu Qu; Shanjin Huang
Journal:  J Biol Chem       Date:  2016-06-03       Impact factor: 5.157

4.  Disease-proportional proteasomal degradation of missense dystrophins.

Authors:  Dana M Talsness; Joseph J Belanto; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

Review 5.  The Dystrophin Complex: Structure, Function, and Implications for Therapy.

Authors:  Quan Q Gao; Elizabeth M McNally
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

6.  Internal deletion compromises the stability of dystrophin.

Authors:  Davin M Henderson; Joseph J Belanto; Bin Li; Hanke Heun-Johnson; James M Ervasti
Journal:  Hum Mol Genet       Date:  2011-05-10       Impact factor: 6.150

7.  Functional correction of dystrophin actin binding domain mutations by genome editing.

Authors:  Viktoriia Kyrychenko; Sergii Kyrychenko; Malte Tiburcy; John M Shelton; Chengzu Long; Jay W Schneider; Wolfram-Hubertus Zimmermann; Rhonda Bassel-Duby; Eric N Olson
Journal:  JCI Insight       Date:  2017-09-21

8.  Dynamics of Dystrophin's Actin-Binding Domain.

Authors:  Michael E Fealey; Benjamin Horn; Christian Coffman; Robert Miller; Ava Y Lin; Andrew R Thompson; Justine Schramel; Erin Groth; Anne Hinderliter; Alessandro Cembran; David D Thomas
Journal:  Biophys J       Date:  2018-06-20       Impact factor: 4.033

9.  CUGC for Duchenne muscular dystrophy (DMD).

Authors:  David J Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-01-12       Impact factor: 4.246

10.  Mouse models of two missense mutations in actin-binding domain 1 of dystrophin associated with Duchenne or Becker muscular dystrophy.

Authors:  Jackie L McCourt; Dana M Talsness; Angus Lindsay; Robert W Arpke; Paul D Chatterton; D'anna M Nelson; Christopher M Chamberlain; John T Olthoff; Joseph J Belanto; Preston M McCourt; Michael Kyba; Dawn A Lowe; James M Ervasti
Journal:  Hum Mol Genet       Date:  2018-02-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.